Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging.

Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Wuertzer CA, Hou H, Chiba S, Yamanouchi K, Leissring M, Petrucelli L, Nishihara M, Hutton ML, McGowan E, Dickson DW, Lewis J.

Am J Pathol. 2010 Jul;177(1):311-24. doi: 10.2353/ajpath.2010.090915. Epub 2010 Jun 3. Erratum in: Am J Pathol. 2010 Oct;177(4):2146. Wuertzer, Charles A [added].

2.

Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration.

Cenik B, Sephton CF, Kutluk Cenik B, Herz J, Yu G.

J Biol Chem. 2012 Sep 21;287(39):32298-306. Epub 2012 Aug 2. Review.

3.

The granulin gene family: from cancer to dementia.

Bateman A, Bennett HP.

Bioessays. 2009 Nov;31(11):1245-54. doi: 10.1002/bies.200900086. Review.

PMID:
19795409
4.

Progranulin and TDP-43: mechanistic links and future directions.

Kumar-Singh S.

J Mol Neurosci. 2011 Nov;45(3):561-73. doi: 10.1007/s12031-011-9625-0. Epub 2011 Aug 24. Review.

5.

Progranulin: an emerging target for FTLD therapies.

Gass J, Prudencio M, Stetler C, Petrucelli L.

Brain Res. 2012 Jun 26;1462:118-28. doi: 10.1016/j.brainres.2012.01.047. Epub 2012 Jan 28. Review.

6.

Structure, function, and mechanism of progranulin; the brain and beyond.

Toh H, Chitramuthu BP, Bennett HP, Bateman A.

J Mol Neurosci. 2011 Nov;45(3):538-48. doi: 10.1007/s12031-011-9569-4. Epub 2011 Jun 21. Review.

PMID:
21691802
7.

Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.

van Swieten JC, Heutink P.

Lancet Neurol. 2008 Oct;7(10):965-74. doi: 10.1016/S1474-4422(08)70194-7. Epub 2008 Sep 2. Review.

PMID:
18771956
8.

Progranulin: normal function and role in neurodegeneration.

Eriksen JL, Mackenzie IR.

J Neurochem. 2008 Jan;104(2):287-97. Epub 2007 Oct 22. Review.

9.

Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

Cruts M, Kumar-Singh S, Van Broeckhoven C.

Curr Alzheimer Res. 2006 Dec;3(5):485-91. Review.

PMID:
17168647
10.

Progranulin in frontotemporal lobar degeneration and neuroinflammation.

Ahmed Z, Mackenzie IR, Hutton ML, Dickson DW.

J Neuroinflammation. 2007 Feb 11;4:7. Review.

11.

Losing protein in the brain: the case of progranulin.

Ghidoni R, Paterlini A, Albertini V, Binetti G, Benussi L.

Brain Res. 2012 Oct 2;1476:172-82. doi: 10.1016/j.brainres.2012.01.075. Epub 2012 Feb 4. Review.

PMID:
22348647
12.

Traumatic brain injury may increase the risk for frontotemporal dementia through reduced progranulin.

Jawaid A, Rademakers R, Kass JS, Kalkonde Y, Schulz PE.

Neurodegener Dis. 2009;6(5-6):219-20. doi: 10.1159/000258704. Epub 2010 Feb 10. Review.

13.

Mechanisms of granulin deficiency: lessons from cellular and animal models.

Kleinberger G, Capell A, Haass C, Van Broeckhoven C.

Mol Neurobiol. 2013 Feb;47(1):337-60. doi: 10.1007/s12035-012-8380-8. Epub 2012 Dec 13. Review.

14.

The Role of PGRN in Alzheimer's Disease.

Jing H, Tan MS, Yu JT, Tan L.

Mol Neurobiol. 2016 Aug;53(6):4189-4196. doi: 10.1007/s12035-015-9358-0. Epub 2015 Jul 28. Review.

PMID:
26215834
15.

Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment.

Suh HS, Gelman BB, Lee SC.

J Neuroimmune Pharmacol. 2014 Mar;9(2):117-32. Review.

16.

Progranulin: a growth factor, a novel TNFR ligand and a drug target.

Liu CJ, Bosch X.

Pharmacol Ther. 2012 Jan;133(1):124-32. doi: 10.1016/j.pharmthera.2011.10.003. Epub 2011 Oct 8. Review.

17.

Cellular effects of progranulin in health and disease.

De Muynck L, Van Damme P.

J Mol Neurosci. 2011 Nov;45(3):549-60. doi: 10.1007/s12031-011-9553-z. Epub 2011 May 25. Review.

PMID:
21611805

Supplemental Content

Support Center